DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duanmu, Z.
Right arrow Articles by Runge-Morris, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duanmu, Z.
Right arrow Articles by Runge-Morris, M.

Vol. 30, Issue 9, 997-1004, September 2002

Effects of Dexamethasone on Aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-Sulfotransferase Gene Expression in Primary Cultured Human Hepatocytes

Zhengbo Duanmu, Deborah Locke, Jeffrey Smigelski, Wei Wu, Michael S. Dahn,1 Charles N. Falany, Thomas A. Kocarek, and Melissa Runge-Morris

Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan (Z.D., D.L., J.S., W.W., T.A.K., M.R.-M.); Department of Surgery, Wayne State University and Department of Veterans Affairs, Detroit, Michigan (M.D.); and Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama (C.N.F.)

To determine whether the dexamethasone (DEX)-inducible hepatic sulfotransferase gene expression that has been described in the rat is conserved in humans, the effects of DEX treatment on hydroxysteroid sulfotransferase (SULT2A1) and aryl sulfotransferase (SULT1A1) gene expression were investigated in primary cultured human hepatocytes. Hepatocytes were prepared from nontransplantable human livers by collagenase perfusion of the left hepatic lobe, and cultured in Williams' medium E that was supplemented with 0.25 U/ml insulin. As reported in the rat, DEX treatment produced concentration-dependent increases in SULT2A1 mRNA and protein expression, with maximum increases observed at concentrations of DEX that would be expected to activate the pregnane X receptor (PXR) transcription factor. In contrast to the rat, in which DEX-inducible SULT1A1 expression has been demonstrated, SULT1A1 expression in primary cultured human hepatocytes was not measurably increased by DEX. In transient transfections conducted in primary cultured rat hepatocytes, the PXR ligands DEX and pregnenolone-16alpha -carbonitrile significantly induced transcription of human and rat SULT2A reporter gene constructs. Cotransfection of either the human or rat SULT2A reporter gene with a PXR dominant negative construct significantly reduced DEX-inducible transcription. These results underscore that while certain features of rat hepatic sulfotransferase gene regulation are conserved in humans, important differences exist across species. The findings also implicate a role for the PXR transcription factor in DEX-inducible rat and human SULT2A gene expression.

1 Present Address: University of Missouri-Kansas City, 2301 Holmes Street, Kansas City, MO 64108.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Toxicol SciHome page
Y. Alnouti
Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification
Toxicol. Sci., April 1, 2009; 108(2): 225 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Gong, M. J. Jarzynka, T. J. Cole, J. H. Lee, T. Wada, B. Zhang, J. Gao, W.-C. Song, D. B. DeFranco, S.-Y. Cheng, et al.
Glucocorticoids Antagonize Estrogens by Glucocorticoid Receptor-Mediated Activation of Estrogen Sulfotransferase
Cancer Res., September 15, 2008; 68(18): 7386 - 7393.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y. Alnouti and C. D. Klaassen
Regulation of Sulfotransferase Enzymes by Prototypical Microsomal Enzyme Inducers in Mice
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 612 - 621.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H.-L. Fang, S. C. Strom, E. Ellis, Z. Duanmu, J. Fu, Z. Duniec-Dmuchowski, C. N. Falany, J. L. Falany, T. A. Kocarek, and M. Runge-Morris
Positive and Negative Regulation of Human Hepatic Hydroxysteroid Sulfotransferase (SULT2A1) Gene Transcription by Rifampicin: Roles of Hepatocyte Nuclear Factor 4{alpha} and Pregnane X Receptor
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 586 - 598.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
B. L. Urquhart, R. G. Tirona, and R. B. Kim
Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs
J. Clin. Pharmacol., May 1, 2007; 47(5): 566 - 578.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y.-H. Huang, C.-Y. Lee, P.-J. Tai, C.-C. Yen, C.-Y. Liao, W.-J. Chen, C.-J. Liao, W.-L. Cheng, R.-N. Chen, S.-M. Wu, et al.
Indirect Regulation of Human Dehydroepiandrosterone Sulfotransferase Family 1A Member 2 by Thyroid Hormones
Endocrinology, May 1, 2006; 147(5): 2481 - 2489.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
P A Sinclair, W J Gilmore, Z Lin, Y Lou, and E J Squires
Molecular cloning and regulation of porcine SULT2A1: relationship between SULT2A1 expression and sulfoconjugation of androstenone.
J. Mol. Endocrinol., April 1, 2006; 36(2): 301 - 311.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Steckelbroeck, B. Oyesanmi, Y. Jin, S.-H. Lee, H. J. Kloosterboer, and T. M. Penning
Tibolone Metabolism in Human Liver Is Catalyzed by 3{alpha}/3beta-Hydroxysteroid Dehydrogenase Activities of the Four Isoforms of the Aldo-Keto Reductase (AKR)1C Subfamily
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1300 - 1309.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Z. Duanmu, A. Weckle, S. B. Koukouritaki, R. N. Hines, J. L. Falany, C. N. Falany, T. A. Kocarek, and M. Runge-Morris
Developmental Expression of Aryl, Estrogen, and Hydroxysteroid Sulfotransferases in Pre- and Postnatal Human Liver
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1310 - 1317.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H.-L. Fang, S. C. Strom, H. Cai, C. N. Falany, T. A. Kocarek, and M. Runge-Morris
Regulation of Human Hepatic Hydroxysteroid Sulfotransferase Gene Expression by the Peroxisome Proliferator-Activated Receptor {alpha} Transcription Factor
Mol. Pharmacol., April 1, 2005; 67(4): 1257 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H.-L. Fang, M. Abdolalipour, Z. Duanmu, J. R. Smigelski, A. Weckle, T. A. Kocarek, and M. Runge-Morris
REGULATION OF GLUCOCORTICOID-INDUCIBLE HYDROXYSTEROID SULFOTRANSFERASE (SULT2A-40/41) GENE TRANSCRIPTION IN PRIMARY CULTURED RAT HEPATOCYTES: ROLE OF CCAAT/ENHANCER-BINDING PROTEIN LIVER-ENRICHED TRANSCRIPTION FACTORS
Drug Metab. Dispos., January 1, 2005; 33(1): 147 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
N. Hempel, H. Wang, E. L. LeCluyse, M. E. McManus, and M. Negishi
The Human Sulfotransferase SULT1A1 Gene Is Regulated in a Synergistic Manner by Sp1 and GA Binding Protein
Mol. Pharmacol., December 1, 2004; 66(6): 1690 - 1701.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. D. Shenoy, T. A. Spencer, N. A. Mercer-Haines, M. Alipour, M. D. Gargano, M. Runge-Morris, and T. A. Kocarek
CYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTOR
Drug Metab. Dispos., January 1, 2004; 32(1): 66 - 71.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
C. Handschin and U. A. Meyer
Induction of Drug Metabolism: The Role of Nuclear Receptors
Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H.-L. Fang, S. Shenoy, Z. Duanmu, T. A. Kocarek, and M. Runge-Morris
TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
Drug Metab. Dispos., November 1, 2003; 31(11): 1378 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. C. Zangar, T. A. Kocarek, S. Shen, N. Bollinger, M. S. Dahn, and D. W. Lee
Suppression of Cytochrome P450 3A Protein Levels by Proteasome Inhibitors
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 872 - 879.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
T. A. Kocarek, M. S. Dahn, H. Cai, S. C. Strom, and N. A. Mercer-Haines
Regulation of CYP2B6 and CYP3A Expression by Hydroxymethylglutaryl Coenzyme A Inhibitors in Primary Cultured Human Hepatocytes
Drug Metab. Dispos., December 1, 2002; 30(12): 1400 - 1405.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.